Related Experiment Video
Updated: Sep 28, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
New Adjunct Therapy for Elevated Lipid Levels.
1Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch:diane.aschenbrenner@gmail.com .
The American Journal of Nursing
|March 29, 2022
Summary
Inclisiran (Leqvio) is a new injectable treatment for adults with high cholesterol. It is approved for patients with familial hypercholesterolemia or atherosclerotic cardiovascular disease who need further LDL cholesterol reduction.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Familial hypercholesterolemia and atherosclerotic cardiovascular disease increase cardiovascular risk.
- Elevated low-density lipoprotein cholesterol (LDL-C) is a primary driver of cardiovascular disease.
- Maximal statin therapy does not adequately reduce LDL-C in all patients.
Purpose of the Study:
- To introduce Inclisiran (Leqvio) as an approved adjunct therapy.
- To highlight its role in managing LDL-C in specific adult patient populations.
Main Methods:
- Inclisiran is administered subcutaneously.
- Treatment is intended as an adjunct to diet and statin therapy.
Main Results:
- Inclisiran provides additional reduction in LDL-C.
- It is approved for adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease.
Conclusions:
- Inclisiran offers a new therapeutic option for patients requiring further LDL-C lowering.
- The subcutaneous administration by a healthcare provider ensures proper delivery.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
925
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
925
01:26Atherosclerosis III: Management
54
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
01:22Heart Failure VI: Adjunct Therapies
47
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
90
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
90
01:24Lipid Absorption
941
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
941
01:26Angina IV: Management
39
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39